⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4246204 | 0.74 | CYP3A4 (0.35) | — | |
| Hexamethylbenzene SCHEMBL114857 | 0.62 | RXFP1 (0.33) | — | |
| SCHEMBL10319934 | 0.61 | — | — | |
| SCHEMBL28754823 | 0.57 | — | — | |
| Hexamethylbenzene SCHEMBL10952799 | 0.57 | RXFP1 (0.31) | — | |
| Hexamethylbenzene SCHEMBL10609849 | 0.57 | RXFP1 (0.31) | — | |
| Hexamethylbenzene SCHEMBL10952629 | 0.57 | RXFP1 (0.31) | — | |
| Hexamethylbenzene SCHEMBL3853890 | 0.57 | RXFP1 (0.31) | — | |
| Hexamethylbenzene SCHEMBL10608743 | 0.57 | RXFP1 (0.31) | — | |
| Hexamethylbenzene SCHEMBL9419367 | 0.57 | RXFP1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7273948-B2 | Process of preparing esters and ethers of probucol and derivatives thereof | ATHEROGENICS, INC. (US) | 2007-09-25 | — | — | US | claimed |
| EP-1594824-A4 | PROCESS OF PREPARING ESTERS AND ETHERS OF PROBUCOL AND DERIVATIVES THEREOF | ATHEROGENICS INC (US) | 2007-04-04 | — | — | EP | claimed |
| EP-1594824-A2 | PROCESS OF PREPARING ESTERS AND ETHERS OF PROBUCOL AND DERIVATIVES THEREOF | Atherogenics, Inc. (US) | 2005-11-16 | — | — | EP | claimed |
| US-20040204485-A1 | Process of preparing esters and ethers of probucol and derivatives thereof | CRABTREE ACQUISITION CO, LLC | 2004-10-14 | — | — | US | claimed |
| WO-2004062622-A2 | PROCESS OF PREPARING ESTERS AND ETHERS OF PROBUCOL AND DERIVATIVES THEREOF | ATHEROGENICS, INC. (US) | 2004-07-29 | — | — | WO | claimed |
| WO-2024184177-A1 | CATIONIC COMPOUNDS FOR ANION EXCHANGE MEMBRANES | AGFA-GEVAERT NV (BE) | 2024-09-12 | — | — | WO | disclosed |
| EP-4424665-A1 | CATIONIC COMPOUNDS FOR ANION EXCHANGE MEMBRANES | AGFA-GEVAERT NV (BE) | 2024-09-04 | — | — | EP | disclosed |
| US-7622604-B2 | via grignard intermediate such as benzylmagnesium chloride and esterification with succinic anhydride; inflammatory and cardiovascular diseases; optimizes the amount of monoester in the final product mixture and minimizes the amount of reagents; e.g. synthesis of succinobucol | SALUTRIA PHARMACEUTICALS LLC (US) | 2009-11-24 | — | — | US | disclosed |
| US-20080009642-A1 | Process of Preparing Esters and Ethers of Probucol and Derivatives Thereof | CRABTREE ACQUISITION CO, LLC | 2008-01-10 | — | — | US | disclosed |
| US-7273948-B2 | Process of preparing esters and ethers of probucol and derivatives thereof | ATHEROGENICS, INC. (US) | 2007-09-25 | — | — | US | disclosed |
| EP-1594824-A4 | PROCESS OF PREPARING ESTERS AND ETHERS OF PROBUCOL AND DERIVATIVES THEREOF | ATHEROGENICS INC (US) | 2007-04-04 | — | — | EP | disclosed |
| EP-1594824-A2 | PROCESS OF PREPARING ESTERS AND ETHERS OF PROBUCOL AND DERIVATIVES THEREOF | Atherogenics, Inc. (US) | 2005-11-16 | — | — | EP | disclosed |
| US-20040204485-A1 | Process of preparing esters and ethers of probucol and derivatives thereof | CRABTREE ACQUISITION CO, LLC | 2004-10-14 | — | — | US | disclosed |
| WO-2004062622-A2 | PROCESS OF PREPARING ESTERS AND ETHERS OF PROBUCOL AND DERIVATIVES THEREOF | ATHEROGENICS, INC. (US) | 2004-07-29 | — | — | WO | disclosed |
| EP-0873328-A1 | SUBSTITUTED 1,2,4,6-THIATRIAZINES USEFUL AS HERBICIDES | Novartis AG (CH) | 1998-10-28 | — | — | EP | disclosed |
| WO-1997025319-A1 | SUBSTITUTED 1,2,4,6-THIATRIAZINES USEFUL AS HERBICIDES | NOVARTIS AG (CH) | 1997-07-17 | — | — | WO | disclosed |